Global Clean Energy Holdings, Inc. Letter to Shareholders
Richard Palmer, Chief Executive Officer LOS ANGELES–(BUSINESS WIRE)–Global Clean Energy Holdings, Inc. (OTCQB: GCEH) has…
News
Protective Closes on AUL Acquisition, Adds Complementary Product Portfolio to Its Asset Protection Division
BIRMINGHAM, Ala.–(BUSINESS WIRE)–Protective Life Corporation, a wholly owned U.S. subsidiary of Dai-ichi Life Holdings, Inc….
BAE Systems Opens Its New Manchester, N.H. Facility, Creating Job Opportunities and Expanding Production Capabilities
MANCHESTER, N.H.–(BUSINESS WIRE)–BAE Systems has opened its new engineering and production facility in Manchester, N.H….
Catchlight Launches to Optimize Lead Qualification for Time-Starved Financial Advisors
AI-powered prospecting data engine debuts at T3 Advisor Conference BOSTON–(BUSINESS WIRE)–Nearly 70% of registered independent…
Duluth Trading Company Transforms In-Store Checkout Experiences with TCS OmniStore™
Tata Consultancy Services’ Unified Commerce Platform Has Helped the Lifestyle Company Enhance Customer Satisfaction, Improve…
Daniel F. Zimmerman Joins Kramer Levin as Partner in Corporate Department
NEW YORK–(BUSINESS WIRE)–Daniel F. Zimmerman has joined Kramer Levin’s New York office as a partner…
Adviser to Ave Maria Mutual Funds and Schwartz Value Focused Fund Announces Reduced Expense Ratios and Portfolio Manager Promotion
PLYMOUTH, Mich.–(BUSINESS WIRE)–Schwartz Investment Counsel, Inc. (the Firm), the investment adviser for the Ave Maria…
Vertical Cold Storage Acquires Three Temperature-Controlled Warehouses From United States Cold Storage
NORTH SIOUX CITY, S.D.–(BUSINESS WIRE)–Vertical Cold Storage, a developer and operator of temperature controlled distribution…
1Kosmos Co-Founder and Chief Strategy Officer to Present at KuppingerCole European Identity and Cloud Conference 2022
Mike Engle will Participate on Two Expert Panels Covering Web3 and Decentralized Identity SOMERSET, N.J.–(BUSINESS…
Codiak Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
– Experienced oncology drug developer with more than two decades advancing treatments for solid tumors and…
Sorrento Announces Full Enrollment of Phase I Study of Intranasal STI-9199 (COVISHIELD™ IN), a Potent Neutralization Antibody Against Omicron BA.2 and All Variants of Concern
The Phase I safety and pharmacokinetic study in 24 healthy volunteers has completed enrollment. The…
Harpoon Therapeutics and Roche to Collaborate on Clinical Trials to Study Novel Immuno-Oncology Combination for Small Cell Lung Cancer
HPN328, Harpoon’s DLL3-targeting T cell engager, to be evaluated in combination with anti-PD-L1 antibody in…
Digipath Validates and Receives Approval to Use Free DNA Removal to Test for Aspergillus
LAS VEGAS, NV, May 02, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Digipath, Inc. (OTCQB:…
CohBar to Announce 2022 First Quarter Financial Results and Provide Business Update on May 16, 2022
Company to host conference call and webcast at 5:00 p.m. ET MENLO PARK, Calif., May…
Sun Sentinel Names Accelus a Winner of the South Florida Top Workplaces 2022 Award
Leading medical technology company recognized for employee engagement and culture PALM BEACH GARDENS, Fla., May…
SciSparc Files Annual Report for Year Ended December 31, 2021 and Provides Corporate Update
TEL AVIV, Israel, May 02, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (NASDAQ: SPRC), a specialty…
Palisade Bio Provides Business Outlook and Highlights Expected Near-Term Pipeline Advancements
Phase 3 study of LB1148 in lead indication for postoperative return of bowel function on…
Healthy Extracts’ First Major Brand Influencer Launches New Line of Natural Health and Fitness Formulations on WhitneyJohns.com
Whitney Johns Product Line The New Whitney Johns Product Line includes BRAIN ACTIVATE (in gel…
FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study
MIAMI, May 02, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company, today…
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Partner Sanofi has commenced dosing in a Phase 2 clinical trial of SAR443820 (DNL788) in…